AU2016363711A1 - Methods of producing glycosylated proteins - Google Patents

Methods of producing glycosylated proteins Download PDF

Info

Publication number
AU2016363711A1
AU2016363711A1 AU2016363711A AU2016363711A AU2016363711A1 AU 2016363711 A1 AU2016363711 A1 AU 2016363711A1 AU 2016363711 A AU2016363711 A AU 2016363711A AU 2016363711 A AU2016363711 A AU 2016363711A AU 2016363711 A1 AU2016363711 A1 AU 2016363711A1
Authority
AU
Australia
Prior art keywords
host cell
protein
target protein
nucleic acid
specific embodiment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2016363711A
Other languages
English (en)
Other versions
AU2016363711A9 (en
Inventor
Markus Aebi
Amirreza Faridmoayer
Ivan HANG
Timothy KEYS
Michael T. Kowarik
Chia-Wei Lin
Christian A. LIZAK
Manuela Mally
Michael L. Wetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Limmatech Biologics AG
Eidgenoessische Technische Hochschule Zurich ETHZ
Original Assignee
Limmatech Biologics AG
Eidgenoessische Technische Hochschule Zurich ETHZ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Limmatech Biologics AG, Eidgenoessische Technische Hochschule Zurich ETHZ filed Critical Limmatech Biologics AG
Publication of AU2016363711A1 publication Critical patent/AU2016363711A1/en
Publication of AU2016363711A9 publication Critical patent/AU2016363711A9/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
    • C12Y207/07—Nucleotidyltransferases (2.7.7)
    • C12Y207/07043—N-Acylneuraminate cytidylyltransferase (2.7.7.43)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2318/00—Antibody mimetics or scaffolds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2016363711A 2015-11-30 2016-11-30 Methods of producing glycosylated proteins Abandoned AU2016363711A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562260725P 2015-11-30 2015-11-30
US62/260,725 2015-11-30
US201662416853P 2016-11-03 2016-11-03
US62/416,853 2016-11-03
PCT/EP2016/079232 WO2017093291A1 (en) 2015-11-30 2016-11-30 Methods of producing glycosylated proteins

Publications (2)

Publication Number Publication Date
AU2016363711A1 true AU2016363711A1 (en) 2018-06-14
AU2016363711A9 AU2016363711A9 (en) 2018-12-13

Family

ID=57460500

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016363711A Abandoned AU2016363711A1 (en) 2015-11-30 2016-11-30 Methods of producing glycosylated proteins

Country Status (7)

Country Link
US (2) US11236136B2 (https=)
EP (1) EP3384018A1 (https=)
JP (1) JP7100584B2 (https=)
CN (1) CN108779443A (https=)
AU (1) AU2016363711A1 (https=)
CA (1) CA3006400A1 (https=)
WO (1) WO2017093291A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019002512A2 (en) 2017-06-30 2019-01-03 Limmatech Biologics Ag GLYCOPROTEINS CUSTOMIZED FROM ENGINEERING AND FULLY FUNCTIONAL
WO2019035916A1 (en) * 2017-08-15 2019-02-21 Northwestern University DESIGN OF PROTEIN GLYCOSYLATION SITES BY RAPID EXPRESSION AND CHARACTERIZATION OF N-GLYCOSYLTRANSFERASES
WO2020044371A1 (en) * 2018-08-29 2020-03-05 Council Of Scientific And Industrial Research Recombinant microbial system for directed evolution of glycocins and a method of preparation thereof
CN109486689B (zh) * 2018-12-27 2020-06-16 江南大学 一种增强l-天冬酰胺酶耐酸性的方法
US20220186276A1 (en) * 2019-01-25 2022-06-16 Northwestern University Platform for producing glycoproteins, identifying glycosylation pathways
CN110117631A (zh) * 2019-05-24 2019-08-13 山东大学 一种利用三种糖基转移酶制备Globotriose-连接的活性糖肽的方法
KR102371465B1 (ko) * 2019-11-08 2022-03-08 영남대학교 산학협력단 코돈 최적화된 캄필로박터제주니 유래 ｎ-아세틸갈락토사민 전이효소와 갈락토즈 전이효소, 및 이를 이용한 대장균 기반의 가용성 전이효소 생산 방법
WO2022053673A1 (en) 2020-09-14 2022-03-17 Limmatech Biologics Ag Fab sialylation of antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1730293A2 (en) 2004-03-17 2006-12-13 Glycofi, Inc. Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
PT1991690E (pt) 2006-03-09 2014-04-22 Centre Nat Rech Scient Método para a produção de oligossacáridos sialilados
EP2501406B8 (en) 2009-11-19 2018-01-24 GlaxoSmithKline Biologicals S.A. Biosynthetic system that produces immunogenic polysaccharides in prokaryotic cells
WO2013020988A1 (en) * 2011-08-08 2013-02-14 Eth Zurich Pasteurellaceae vaccines
US20160032344A1 (en) * 2013-03-15 2016-02-04 Glycobia, Inc. Polysialic acid, blood group antigens and glycoprotein expression in prokaryotes

Also Published As

Publication number Publication date
AU2016363711A9 (en) 2018-12-13
WO2017093291A9 (en) 2018-07-12
US20180354997A1 (en) 2018-12-13
US20220242919A1 (en) 2022-08-04
CN108779443A (zh) 2018-11-09
EP3384018A1 (en) 2018-10-10
US11236136B2 (en) 2022-02-01
WO2017093291A1 (en) 2017-06-08
JP7100584B2 (ja) 2022-07-13
CA3006400A1 (en) 2017-06-08
JP2019502401A (ja) 2019-01-31

Similar Documents

Publication Publication Date Title
US20220242919A1 (en) Methods of producing glycosylated proteins
US20240287568A1 (en) Engineered and Fully-Functional Customized Glycoproteins
JP7684310B2 (ja) Ｌｅｉｓｈｍａｎｉａ細胞を使用する糖鎖修飾改変
CA2711307C (en) Glycosylated protein expression in prokaryotes
Keys et al. A biosynthetic route for polysialylating proteins in Escherichia coli
WO2017010559A1 (ja) 新規ＥｎｄｏＳ変異酵素
Lauber et al. Expression of the functional recombinant human glycosyltransferase GalNAcT2 in Escherichia coli
EP2142660A2 (en) Methods and systems for o-glycosylating proteins
KR20160021075A (ko) 올리고사카라이드 조성물, 당단백질, 및 원핵생물에서의 이들의 제조 방법
JP2016518825A (ja) ポリシアル酸、血液型抗原および糖タンパク質の発現
WO2024068768A1 (en) Glycoengineering using leishmania cells
Yuan et al. Construction and optimization of a microbial platform for sustainable biosynthesis of poly-N-acetyllactosamine glycoprotein in the cytoplasm for detecting tumor biomarker galectin-3
JP2026067872A (ja) 改変されかつ完全に機能カスタマイズされた糖タンパク質
Müller Sweet factory: an O-glycosylation competent Escherichia coli strain for the recombinant expression of complex biopharmaceuticals
McMahon Structural and functional characterisation of lectins from the PA-IL superfamily

Legal Events

Date Code Title Description
SREP Specification republished
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period